BRIEF-Novartis To Buy Tourmaline Bio

Reuters

2025/09/09

BRIEF-Novartis To Buy <a href="https://laohu8.com/S/TRML">Tourmaline Bio</a>

Sept 9 (Reuters) - NOVARTIS AG NOVN.S:

TO ACQUIRE TOURMALINE BIO, COMPLEMENTING CARDIOVASCULAR PIPELINE WITH PACIBEKITUG FOR THE TREATMENT OF ATHEROSCLEROTIC CARDIOVASCULAR DISEASE (ASCVD)
OFFER PRICE USD 48 PER SHARE, COMPANY VALUED AT USD 1.4BN
EXPECTS TO MERGE ACQUIRING SUBSIDIARY WITH AND INTO TOURMALINE
TRANSACTION IS EXPECTED TO CLOSE IN Q4 OF 2025

Source text: ID:nGNE7bpPpy

Further company coverage: NOVN.S

(Gdansk Newsroom)

((Gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))

应版权方要求，你需要登录查看该内容

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/news/2566636516"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2566636516\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2566636516?lang=zh_CN&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-09-09 13:05","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2566636516","market":"fut","top_or_hot":-1,"title":"BRIEF-Novartis To Buy Tourmaline Bio","media":"Reuters","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>BRIEF-Novartis To Buy <a href=\"https://laohu8.com/S/TRML\">Tourmaline Bio</a></title></head><body><p><span>Sept 9 (Reuters)</span><span> - </span>NOVARTIS AG <span>NOVN.S</span>:</p><ul><li><p>TO ACQUIRE TOURMALINE BIO, COMPLEMENTING CARDIOVASCULAR PIPELINE WITH PACIBEKITUG FOR THE TREATMENT OF ATHEROSCLEROTIC CARDIOVASCULAR DISEASE (ASCVD)</p></li><li><p>OFFER PRICE USD 48 PER SHARE, COMPANY VALUED AT USD 1.4BN</p></li><li><p>EXPECTS TO MERGE ACQUIRING SUBSIDIARY WITH AND INTO TOURMALINE</p></li><li><p>TRANSACTION IS EXPECTED TO CLOSE IN Q4 OF 2025</p></li></ul><p>Source text: <span>ID:nGNE7bpPpy</span></p><p>Further company coverage: <span>NOVN.S</span></p><p> (Gdansk Newsroom)</p><p> ((Gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))</p></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>BRIEF-Novartis To Buy Tourmaline Bio</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBRIEF-Novartis To Buy Tourmaline Bio\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2025-09-09 13:05</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>BRIEF-Novartis To Buy <a href=\"https://laohu8.com/S/TRML\">Tourmaline Bio</a></title></head><body><p><span>Sept 9 (Reuters)</span><span> - </span>NOVARTIS AG <span>NOVN.S</span>:</p><ul><li><p>TO ACQUIRE TOURMALINE BIO, COMPLEMENTING CARDIOVASCULAR PIPELINE WITH PACIBEKITUG FOR THE TREATMENT OF ATHEROSCLEROTIC CARDIOVASCULAR DISEASE (ASCVD)</p></li><li><p>OFFER PRICE USD 48 PER SHARE, COMPANY VALUED AT USD 1.4BN</p></li><li><p>EXPECTS TO MERGE ACQUIRING SUBSIDIARY WITH AND INTO TOURMALINE</p></li><li><p>TRANSACTION IS EXPECTED TO CLOSE IN Q4 OF 2025</p></li></ul><p>Source text: <span>ID:nGNE7bpPpy</span></p><p>Further company coverage: <span>NOVN.S</span></p><p> (Gdansk Newsroom)</p><p> ((Gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"TRML","symbol_name":"Tourmaline Bio","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250909:nL5N3UW02Y:1","article_id":"2566636516","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2566636516","pubTimestamp":1757394307,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"BRIEF-Novartis To Buy Tourmaline BioSept 9 (Reuters) - NOVARTIS AG NOVN.S:TO ACQUIRE TOURMALINE BIO, COMPLEMENTING CARDIOVASCULAR PIPELINE WITH PACIBEKITUG FOR THE TREATMENT OF ATHEROSCLEROTIC CARDIOV","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"TRML":"Tourmaline Bio","BK4539":"次新股","BK4139":"生物科技"},"translate_title":"简介-诺华收购Tourmaline Bio","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"TRML":0.9},"content_text":"BRIEF-Novartis To Buy Tourmaline BioSept 9 (Reuters) - NOVARTIS AG NOVN.S:TO ACQUIRE TOURMALINE BIO, COMPLEMENTING CARDIOVASCULAR PIPELINE WITH PACIBEKITUG FOR THE TREATMENT OF ATHEROSCLEROTIC CARDIOVASCULAR DISEASE (ASCVD)OFFER PRICE USD 48 PER SHARE, COMPANY VALUED AT USD 1.4BNEXPECTS TO MERGE ACQUIRING SUBSIDIARY WITH AND INTO TOURMALINETRANSACTION IS EXPECTED TO CLOSE IN Q4 OF 2025Source text: ID:nGNE7bpPpyFurther company coverage: NOVN.S (Gdansk Newsroom) ((Gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"corporation","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":true,"code":"91000000","status":"200"}}}